Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2.

Declan McLaughlinYouyou ZhaoKarla M O'NeillKevin S EdgarPhilip D DunneAnna M KearneyDavid J GrieveBarbara J McDermott

Published in: British journal of pharmacology (2017)

This article is part of a themed section on New Insights into Cardiotoxicity Caused by Chemotherapeutic Agents. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.21/issuetoc.

Keyphrases

high glucose
heart failure
diabetic rats
drug delivery
benign prostatic hyperplasia
lower urinary tract symptoms
cancer therapy
drug induced